Cargando…

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ(®) tablets

House-dust mites (HDM) allergy is the prevailing condition in subjects allergic to inhalants. Clinical studies with HDM extracts—either subcutaneous (SCIT) or sublingual (SLIT) have long been characterized by small sample size, varying allergen doses, and poorly defined endpoints assessing disease s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitiello, Gianfranco, Maltagliati, Lucia, Rossi, Oliviero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288442/ https://www.ncbi.nlm.nih.gov/pubmed/32536827 http://dx.doi.org/10.1186/s12948-020-00124-7

Ejemplares similares

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed
por: Mösges, Ralph, et al.
Publicado: (2021)

SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma
por: Blumberga, G, et al.
Publicado: (2011)

Erratum: In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2017)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Acute systemic reactions to sublingual immunotherapy for house dust mite
por: Janssens, Nicky S., et al.
Publicado: (2020)

Treatment of Patients with Refractory Atopic Dermatitis Sensitized to House Dust Mites by Using Sublingual Allergen Immunotherapy
por: Choi, Joon-Seok, et al.
Publicado: (2015)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy
por: Aarestrup, Matheus Fonseca, et al.
Publicado: (2021)

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019)

O17 - Assessment of efficacy and safety of sublingual tablets of house dust mite allergen extract in children and adolescents with allergic rhinitis
por: Halken, Susanne, et al.
Publicado: (2014)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

Cost-effectiveness of SQ(®) HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany
por: Green, William, et al.
Publicado: (2017)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

159 Therapeutic Effect and Safety of the Sublingual Immunotherapy With Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patients
por: Castro Almarales, Raúl Lázaro, et al.
Publicado: (2012)

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
por: Hahn-Pedersen, J., et al.
Publicado: (2016)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

Sublingual Immunotherapy for Asthmatic Children Sensitized to House Dust Mite: A Meta-Analysis
por: Liao, Wei, et al.
Publicado: (2015)

Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites
por: Kim, Ji Hye, et al.
Publicado: (2018)

Effectiveness of sublingual immunotherapy with house dust mite drops in asthmatic children at different ages
por: Ai, Tao, et al.
Publicado: (2023)

Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
por: HUI, YU, et al.
Publicado: (2014)

Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children
por: Lim, Jae Hyun, et al.
Publicado: (2017)

Effect of high-dose sublingual immunotherapy on respiratory infections in children allergic to house dust mite
por: Barberi, Salvatore, et al.
Publicado: (2015)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017)

Variability of house dust mite allergen exposure in dwellings.
por: Hirsch, T, et al.
Publicado: (1998)

Allergens with Protease Activity from House Dust Mites
por: Reithofer, Manuel, et al.
Publicado: (2017)

Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: A randomized trial in a pediatric population
por: Okamoto, Yoshitaka, et al.
Publicado: (2018)

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
por: Frati, Franco, et al.
Publicado: (2012)

The usefulness of the basophil activation test in monitoring specific immunotherapy with house dust mite allergens
por: Czarnobilska, Ewa M., et al.
Publicado: (2018)

Clinical evaluation of rush immunotherapy using house dust mite allergen in Japanese asthmatics
por: Uchida, Takahiro, et al.
Publicado: (2021)

The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites
por: Bogacz-Piaseczyńska, Agnieszka, et al.
Publicado: (2022)

Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites
por: Kim, Shin Hye, et al.
Publicado: (2015)

A 12‐week DBPC dose‐finding study with sublingual monomeric allergoid tablets in house dust mite‐allergic patients
por: Hüser, C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_la7tqkoqja012pj453dd90k0kk